TrialHuman gene therapy. Clinical development2018

Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.

Stéphane Palfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.